The Global Cell Therapy Market was valued at US$ 7.7 billion in 2020, and it is expected to reach US$ 19.5 billion by 2027, with a CAGR of 14.2%, during the forecast period, 2021 - 2027.
A therapy in which the human cells are used to repair or replace the damaged tissue. Through this way it helps to treat many disorders and resolves many health issues. The rising research activity and developments in the field of cell therapy enabled many different cells to use as a therapy for various diseases. The cells used in this therapy are such as dendritic cells, skeletal muscle stem cells, lymphocytes, mesenchymal stem cells, hematopoietic stem cells, and others. Evolving research activity has made it possible to develop novel cell therapies and are successfully utilized to treat various disorders across the globe. The key applications of cell therapy include cancer treatment, urinary issues, autoimmune disease, spinal cord related injuries, infectious disease treatment, immune system improvement, and in the treatment of several neurological disorders.
Rising health issues, growing obese and ageing population across the globe are some of the key factors driving growth of the global cell therapy market. The obesity is a leading cause of various chronic disease the owing to unhealthy diet habits the obesity is growing rapidly across the globe. This in turn driving demand for cell therapies specially in developed countries across the globe. Moreover, rising number of cancer infected individuals is also generating huge demand for the cell therapy and is expected to support growth of the global market over the forecast period.
Based on cell type, the global cell therapy market can be segmented as stem cell, bone marrow, blood, umbilical cord-derived, adipose-derived stem cell, others, and non-stem cell. Among these, stem cell therapy holds the largest share in the cell therapy industry and is expected to show a high growth during the forecast period. Increasing funding for research activities stem cell field is driving growth of the stem cell segment growth.
There has been an increase in the demand for cancer treatment which is another major factor supporting research activity and is fuelling growth of this segment market.
On the basis of therapeutic area, the global cell therapy market can be segmented as malignancies, musculoskeletal disorders, autoimmune disorders, dermatology, and other therapies. The malignancies segment has accounted for the largest share in the cell therapy market in 2020 and will continue to hold its market position throughout the forecast period. Increasing obese population and majority of individuals suffering from malignant tumour are seeking for cell therapy. This is a key factor driving growth of the global market.
However, autoimmune disease segment is expected to register a notable growth owing to rising prevalence of various autoimmune disease such as rheumatoid arthritis across the globe.
On the basis of therapy type, the global cell therapy market can be segmented as autologous and allogeneic. The autologous therapy segment has accounted for the largest share in the cell therapy market in 2020 and will continue to hold its market position throughout the forecast period. This therapy is considered ideal cell therapy as it induces growth of own stem cells in the human body. This is considered as a key treatment option in the cancer treatment; hence this segment is expected to witness a high growth in the near future.
Many patients opt for this treatment post chemotherapy. This treatment helps to kill cancerous cells which are remained post chemotherapy. Hence, this is another factor driving growth of this segment market.
On the basis of region, the global cell therapy market can be segmented as North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The North America region currently dominates the global cell therapy market. This is owing to presence of necessary infrastructure, key companies, and skilled labours in countries in the region. Moreover, high funding availability for research activities is another factor supporting North America market.
However, Asia Pacific region is expected to register highest growth during the forecast period. According to the World Bank, in terms of population Asia Pacific region is dominating the global market. Also, as per the Population Reference Bureau, India, China, and other emerging APAC countries had a combined population exceeding 4 billion in 2020. Growing income level of individuals residing in this region and improving healthcare facilities are some other factors supporting regional market. China is expected to hold the largest share in this region followed by India.
The COVID-19 outbreak has made a positive impact on cell therapy market. Outbreak of COVID- 19 results in delay for the treatment of cancer so the cancer patients opting the chimeric antigen receptor T-cell (CAR-T) therapy or hematopoietic cell transplantation (HCT) which is the major driving factor for the growth of the cell therapy market during this pandemic. Additionally, government also supporting cell banks also during this pandemic as demand of cell therapy increasing among the cancer patients is another boosting factor for the growth of target market. Stem cells therapy also is under research to trat sever Covid-19. Hence, investment by market players to develop therapy for Covid-19 is expected to accelerate the market growth.
|1||The cell therapy industry is witnessing a rising trend of strategic initiatives by key players such as collaborations for research and product development. Additionally, significant investment for R&D activity||Positive|
|2||Rising number of stem cell banks and increasing government support for stem cell banking are some other trends witnessed in the global market. In many countries stem cell banking has recently started and is gaining a significant growth.||Positive|
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports